As the world continues to heal from the scars left by the COVID-19 pandemic, a monumental diplomatic effort is unfolding behind the closed doors of the World Health Organization (WHO) headquarters in Geneva. Member states have formally agreed to continue high-stakes negotiations on a proposed global pandemic agreement, marking a critical step toward securing a legally binding instrument designed to prevent a future global health catastrophe. With the Seventy-seventh World Health Assembly scheduled for May 27, 2024, the pressure is mounting to refine a draft that has been over two years in the making.
The Core Mandate: Forging a Path to Global Security
The objective of the Intergovernmental Negotiating Body (INB)—the state-led entity spearheading these talks—is to create a framework that ensures the world is never again caught as unprepared as it was in early 2020. The current negotiations are focused on several "make-or-break" pillars:
- Pathogen Access and Benefit Sharing (PABS): Establishing a fair, transparent system where countries share information on emerging pathogens in exchange for guaranteed, equitable access to the resulting medical countermeasures, including vaccines, therapeutics, and diagnostics.
- One Health Integration: A commitment to understanding the nexus between human, animal, and environmental health, acknowledging that the majority of emerging infectious diseases originate in the animal kingdom.
- Financial Coordination: Creating sustainable, scalable funding mechanisms to bolster national health systems, particularly in low- and middle-income countries, ensuring that preparedness is not a privilege reserved for the wealthy.
These issues represent the most challenging aspects of the treaty, as they touch upon national sovereignty, intellectual property rights, and the delicate balance between global public goods and commercial interests.
A Chronology of a Global Commitment
The quest for a pandemic treaty did not emerge in a vacuum; it is the culmination of a realization that the existing International Health Regulations (IHR) were insufficient to manage a crisis of the scale of COVID-19.
- March 2021: In a rare display of global solidarity, heads of state and government from two dozen nations—including the UK, France, Germany, and Kenya—issued a joint statement. They called for a new international treaty to bolster global resilience, arguing that "no single government or multilateral agency can address the threat of future pandemics alone."
- December 2021: Following months of preliminary discussions, WHO Member States officially launched the Intergovernmental Negotiating Body (INB). This marked the formal start of the drafting process, with the explicit goal of creating a "legally binding convention, agreement or other international instrument."
- 2022–2023: Two years of intensive, often grueling negotiations followed. These sessions involved thousands of hours of debate, dozens of draft iterations, and significant friction regarding the distribution of medical supplies and the scope of sovereign control.
- April 2024: Governments meeting in Geneva reached a pivotal consensus to continue the hybrid and in-person discussions, acknowledging that while the finish line is in sight, the final details remain complex.
The Philosophical Underpinnings: "If, Not When"
The rhetoric from the INB leadership underscores the existential nature of these talks. Mr. Roland Driece, Co-Chair of the INB from the Netherlands, has been a vocal proponent of the "urgency of now."
"These sovereign states did so recognizing that great collaboration and coordination were needed in the face of pandemics," Driece stated during the latest briefing. "While negotiations have been challenging at times, all countries agree that the world must be better prepared for the next pandemic. It is not a matter of if a pandemic will happen again; it is a matter of when. We cannot afford to miss this historic opportunity."
This sentiment is echoed by his co-chair, Dr. Precious Matsoso of South Africa, who views the process as a transformative moment in international law. "We are witnessing history play out before our eyes," she noted. "Getting this done means getting it right, and the INB Bureau is committed to helping finalize a meaningful, lasting agreement."
Implications: A New Era of Health Governance
The implications of a successful treaty are profound. If ratified, the agreement would mark the first time the global community has created a binding mechanism specifically for pandemic prevention.
Bridging the North-South Divide
A central implication of the treaty is the attempt to bridge the "equity gap." During the COVID-19 pandemic, lower-income nations were often left at the back of the queue for life-saving vaccines. The proposed PABS system aims to mandate that a percentage of pharmaceutical production be set aside for global distribution during emergencies, potentially limiting the "vaccine nationalism" that defined the 2020–2021 period.
Strengthening Health Infrastructure
The treaty aims to elevate pandemic preparedness from a temporary "emergency response" mindset to a permanent "institutional capacity" model. This includes building the surveillance infrastructure needed to detect zoonotic spillovers before they reach human populations, and creating regional manufacturing hubs to decentralize the production of medical supplies.
Sovereignty and Enforcement
Critics of the treaty often point to concerns over national sovereignty—the fear that the WHO could gain undue influence over national health policies. However, the INB maintains that the treaty is a tool for cooperation, not control. The text is being crafted to respect the sovereign rights of states while creating a framework of mutual accountability.
WHO Director-General’s Perspective
Dr. Tedros Adhanom Ghebreyesus, the Director-General of the WHO, has been the primary champion of this agreement. His message remains one of unwavering, if cautious, optimism.
"During more than two years of intensive negotiations, WHO’s Member States have shown unwavering commitment to forging a generational agreement to protect the world from a repeat of the horrors caused by the COVID-19 pandemic," Dr. Tedros said. "I welcome the determination that all countries have shown to continue their work and fulfill the mission on which they embarked."
For Dr. Tedros, this treaty is the legacy project of his tenure. He has repeatedly warned that the current "cycle of panic and neglect" is the greatest threat to global health security. By embedding prevention into international law, the WHO hopes to break this cycle once and for all.
The Road to May 27th
As the international community looks toward the Seventy-seventh World Health Assembly, the path forward is clear but arduous. The coming weeks will see a flurry of diplomatic activity as negotiators attempt to reconcile the final sticking points regarding benefit sharing and financing.
If successful, the treaty will be presented to the World Health Assembly for adoption. Its ratification would represent a rare success story in an era of geopolitical fragmentation—a testament to the idea that in the face of microscopic, invisible threats, the nations of the world are stronger when they act as one.
The world waits to see if the rhetoric of "unprecedented collaboration" will translate into the hard, binding commitments necessary to secure the health of future generations. The history of international diplomacy is littered with ambitious projects that failed at the final hurdle; however, the consensus in Geneva remains that for this particular challenge, failure is not an option. The clock is ticking, and the next pandemic remains a statistical certainty that the world can no longer afford to ignore.
About the Author
